drugset / Trial / NCT01609959

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

NCT01609959

Phase 4 Completed 70 enrolled Nara Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare blood pressure lowering effect of azilsartan with that of valsartan in Japanese patients with hypertension who have already taken normal-dose angiotensin II receptor blockers.

Timeline

Start
2012-06
Primary completion
2013-09
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azilsartan Unknown 20 mg
Comparator Azilsartan Unknown 40 mg
Comparator Valsartan Small molecule 160 mg

Indications